Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces

BACKGROUND: Confidential product listing agreements (PLAs) negotiated between pharmaceutical manufacturers and individual health care payers may contribute to unwanted price disparities, high administrative costs, and unequal bargaining power within and across jurisdictions. In the context of Canada...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Steven G, Thomson, Paige A, Daw, Jamie R, Friesen, Melissa K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563436/
https://www.ncbi.nlm.nih.gov/pubmed/23363626
http://dx.doi.org/10.1186/1472-6963-13-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563436/
https://www.ncbi.nlm.nih.gov/pubmed/23363626
http://dx.doi.org/10.1186/1472-6963-13-34

Ejemplares similares